Does BPC-157 Help A2 Pulley Injuries?

Does BPC-157 help an A2 pulley injury? There’s no settled answer — just a debate. Climbers who try it say the peptide takes the edge off a healing pulley and gets them crimping again sooner, on the idea that BPC-157 speeds tendon and ligament repair. Skeptics push back that the story leans on a rat-tendon study rather than a human finger, and that a torn pulley heals on its own clock either way. Below is both sides — plus how the injury gets graded, since that’s what climbers argue over first.

The full rundown — grading, the case for BPC-157, and the case against ↓

Felt a pop on a crimp? You may have hurt a pulley. The A2 pulley, near the base of the finger, takes the most load on a crimp, so it’s the one climbers hurt most.

What is an A2 pulley injury?

Doctors grade these from I to IV:

  • Grade I — a strain, no tear.
  • Grade II — one pulley torn.
  • Grade III — one torn, plus damage nearby.
  • Grade IV — several torn, often with bowstringing (the tendon lifting off the bone).

A few things set your path from here:

  • The grading system comes from Volker Schöffl’s team, built from real climbing injuries.[1]
  • The grade sets your timeline — and whether surgery is even a question.
  • An ultrasound, not how it felt, is what confirms it.[2]

What are BPC-157 and TB-500?

  • BPC-157 is a lab-made peptide sold online for tissue repair. The name is short for “Body Protection Compound,” and its recipe comes from a protein found in human stomach fluid.
  • TB-500 is usually sold with it — the pair is nicknamed the Wolverine stack. It’s a lab-made fragment of a natural protein called thymosin β4, which has been through human trials only for dry eye, given as an eye drop.[4]

Why do climbers use it for a pulley injury?

The logic climbers and sellers work from is simple: a torn pulley is a repair job, and BPC-157 is described in lab research as acting on the machinery that repair depends on. The specific claims:

  • Tendon cell growth. A 2011 lab study found BPC-157 helped tendon cells (tenocytes) move, grow, and survive stress in a dish.[8]
  • New blood vessels. Part of the reasoning is angiogenesis — growing new blood vessels. On the Huberman Lab podcast, that effect was described as its proposed healing mechanism[12] — which appeals to climbers because the pulley is a thin band with little blood supply to begin with.
  • Healing a cut tendon. A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal.[7]
  • The TB-500 angle. Thymosin β4, the protein TB-500 is a piece of, is described in the research as a protein that helps repair injured tissue[3] — and users apply that to the pulley.

What climbers actually use it for, going by their posts:

  • A pulley that popped on a crimp and hasn’t settled with rest.
  • A grade II or III tear they’re managing without surgery.
  • Most often, the long stretch between the injury and hard climbing, where they want to shorten the timeline.

How do people use it?

  • On peptide forums like MESO-Rx and LongeCity, users describe injecting BPC-157 — often stacked with TB-500 — for tendon and joint injuries.[5]
  • Fake or underdosed product is a constant worry.
  • Some users even crowdfund third-party lab testing to check what’s actually in their vials.[6]

What do users report?

Reports on peptide forums are mixed — some describe fast relief, others say it did nothing.[5][10]

What some users report (anecdotal)

  • Faster pain relief
  • More energy
  • Quicker return to climbing

What other users report (anecdotal)

  • No effect at all
  • Wasted money on fakes
  • Doubts it does anything

Two things worth keeping in mind about these:

  • They’re self-selected reports from anonymous posters, not measured outcomes.
  • Pulley injuries also heal on their own over time — and BPC-157 is almost always taken with TB-500, so a report rarely separates one from the other.

What side effects are reported?

BPC-157 has no formal safety studies in people, so there’s no official side-effect list — just forum reports and expert caution. (One account’s tally of 106 community self-reports on X found about 55% said their problem improved and about 17% said they got worse overall.)

Reported by forum users (anecdotal)

  • Injection-site pain, redness
  • Nausea
  • Heart palpitations
  • Fatigue
  • Mood changes
  • Emotional blunting (anhedonia)
  • Headaches
  • Dizziness
  • Metallic taste
  • Under-eye puffiness

Off-label upsides some users report (anecdotal)

  • Better mood
  • Less anxiety
  • Hair growth
  • Clearer skin
  • Fewer alcohol cravings

A few specifics from the forums:

  • Users on Reddit’s r/bpc_157, r/Peptides, and r/TBI describe heart palpitations and a jump in resting heart rate — one reported it climbing from 66 to 96 bpm all day, with dull chest pain.
  • Another, in r/TBI, described a severe inflammatory reaction — “joint inflammation so bad I can barely walk” — after trying BPC-157 from two different sources, both oral and injected.
  • Emotional blunting (anhedonia — a flat, joyless feeling) shows up in dedicated threads; users tie it to BPC-157’s effect on dopamine, and some say it eases over days to weeks after they stop.
  • Purity is all over the map — gray-market testing has found some BPC-157 as low as about 55% pure.

And from people with a public platform:

  • Physician Peter Attia puts BPC-157 in his lowest-confidence group, noting its animal results haven’t been repeated in people.[11]
  • On the Huberman Lab podcast, the main concerns raised were product sourcing and a theoretical cancer risk, since BPC-157 can promote blood-vessel growth.[12]
  • In 2023, the FDA placed BPC-157 in a restricted compounding category, citing concerns like immune reactions and impurities.[13]

What’s the standard approach to a pulley injury?

For context on what a peptide would sit alongside or instead of:

  • Get the grade right. Ultrasound, not guessing, sets the timeline.[2]
  • Load it, don’t just rest it. Tendon tissue responds to gradual load, not only time off.[14]
  • Tape and no-hangs. H-taping and light finger holds while it heals.
  • Add load slowly. The same slow-loading approach studied in chronic Achilles tendons is applied here.[15]

What do the studies say?

No study — human or animal — has tested BPC-157 or TB-500 on a finger pulley. The research the theory rests on is about a different tissue, in a different species:

  • A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal.[7]
  • A 2011 lab study found it helped tendon cells move, grow, and survive stress in a dish.[8]
  • A 2025 review of 544 BPC-157 papers found 35 animal studies and one human study — a small case series on knee pain, not a controlled trial, and nothing about fingers.[9]
  • TB-500 has no human trial of its own; the human trials of thymosin β4, the protein it’s a piece of, are for dry eye and use an eye drop.[4]

Bottom line

  • Climbers use BPC-157 and TB-500 on a torn pulley on the strength of the lab work — tendon-cell growth, new blood vessels, and a rat Achilles that healed faster.
  • What users report is mixed, and the two are nearly always taken together, so it’s hard to credit either one alone.
  • No study has tested either one on a pulley, in people or in animals — what exists is animal and cell-culture work.
  • The alternative climbers usually get steered to is graded rest and slow, progressive loading.

Frequently asked questions

Has BPC-157 been studied for an A2 pulley injury?
No. There is no human or animal study of BPC-157 for a finger pulley injury. A 2025 research review found the supporting data comes from rat Achilles tendons and cell studies, not fingers.
What does a pop on a crimp mean?
It often means a pulley tore. A pop with pain, and in bad cases the tendon lifting off the bone (bowstringing), usually points to a partial or full A2 pulley tear (Schöffl grade II–IV). An ultrasound confirms the grade.
Is TB-500 better supported than BPC-157 for this?
No. TB-500 is a lab-made piece of a protein called thymosin β4. That protein has human studies only for dry eye, not tendons or pulleys. There is no TB-500 pulley data at all.

References

  1. Schöffl V, Hochholzer T, Winkelmann HP, Strecker W. Pulley injuries in rock climbers. Wilderness Environ Med. 2003. PMID: 12825883.
  2. Miro PH, vanSonnenberg E, Sabb DM, Schöffl V. Finger Flexor Pulley Injuries in Rock Climbers. Wilderness Environ Med. 2021. PMID: 33966972.
  3. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005. PMID: 16099219. DOI: 10.1016/j.molmed.2005.07.004.
  4. RegeneRx Biopharmaceuticals (RGN-259 program). Thymosin β4 ophthalmic solution (RGN-259) in dry eye: randomized controlled trial. Clin Ophthalmol. 2015. DOI: 10.2147/OPTH.S80954.
  5. MESO-Rx forum members BPC-157 — community discussion thread MESO-Rx forum. n.d.. Source.
  6. MESO-Rx forum members Community peptide lab-testing (Janoshik) thread MESO-Rx forum. n.d.. Source.
  7. Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006. PMID: 16583442. DOI: 10.1002/jor.20096.
  8. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011. PMID: 21148156. DOI: 10.1152/japplphysiol.00945.2010.
  9. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. PMID: 40756949. DOI: 10.1177/15563316251355551.
  10. LongeCity forum members BPC-157 — community megathread LongeCity forum. n.d.. Source.
  11. Attia P AMA #83: Peptides — evaluating the science, safety, and hype The Peter Attia Drive (podcast). n.d.. Source.
  12. Huberman A Benefits & Risks of Peptide Therapeutics for Physical & Mental Health Huberman Lab (podcast). n.d.. Source.
  13. U.S. Food and Drug Administration 19 peptides placed in Category 2 of the interim 503A bulks list (safety concerns: immunogenicity, peptide-related impurities) FDA regulatory action, Sept 29, 2023. 2023. Source.
  14. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009. PMID: 18812414. DOI: 10.1136/bjsm.2008.051193.
  15. Alfredson H, Pietilä T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998. PMID: 9617396. DOI: 10.1177/03635465980260030301.